• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性原发性肿瘤的转移性癌。对254例患者的研究。

Metastatic carcinomas from occult primary tumors. A study of 254 patients.

作者信息

Didolkar M S, Fanous N, Elias E G, Moore R H

出版信息

Ann Surg. 1977 Nov;186(5):625-30. doi: 10.1097/00000658-197711000-00014.

DOI:10.1097/00000658-197711000-00014
PMID:921356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1396304/
Abstract

From 1950 to 1973, 254 patients with metastatic cancers from occult primary tumors, comprising 0.5% of all the referred cancer patients were seen. The average age was 59 years. Clinical presentation was commonly in the form of metastatic lesions in lung, cervical lymph node, bone or liver. Radiological and radioisotopic investigations proved helpful in determining the extent of disease rather than the origin of primary tumor. Adenocarcinoma was the commonest type, followed by undifferentiated and squamous cell carcinomas. The origin of the primary tumor was established in 77 (30%) patients, mostly at autopsy. It was in the lung in 40% of the cases, followed by stomach, pancreas, kidney, ovary and colon. Some correlation was found between clinical presentation and the origin of the primary tumor. Histologically different second cancers were detected in 28 (11%) patients. Overall median and five-year survival rates were nine months and nine per cent respectively. Longer survival was seen in patients with squamous cell carcinoma metastases, middle and upper neck lymph node lesions, and those who had "curative" surgery. In localized metastatic lesions, surgical extirpation should be done. Depending on the histological type of the metastatic lesions, chemotherapy and/or radiation therapy have definite roles in the management of these patients. Periodic follow-up examinations also prove valuable.

摘要

1950年至1973年期间,共诊治了254例隐匿性原发肿瘤转移癌患者,占所有转诊癌症患者的0.5%。平均年龄为59岁。临床表现通常为肺部、颈部淋巴结、骨骼或肝脏的转移病灶。放射学和放射性同位素检查有助于确定疾病范围,而非原发肿瘤的起源。腺癌是最常见的类型,其次是未分化癌和鳞状细胞癌。77例(30%)患者的原发肿瘤起源得以确定,大多是在尸检时。40%的病例起源于肺部,其次是胃、胰腺、肾脏、卵巢和结肠。在临床表现与原发肿瘤起源之间发现了一些相关性。28例(11%)患者检测到组织学上不同的第二原发癌。总体中位生存期和五年生存率分别为9个月和9%。鳞状细胞癌转移、颈中上部淋巴结病变以及接受“根治性”手术的患者生存期较长。对于局限性转移病灶,应进行手术切除。根据转移病灶的组织学类型,化疗和/或放疗在这些患者的治疗中具有明确作用。定期随访检查也很有价值。

相似文献

1
Metastatic carcinomas from occult primary tumors. A study of 254 patients.隐匿性原发性肿瘤的转移性癌。对254例患者的研究。
Ann Surg. 1977 Nov;186(5):625-30. doi: 10.1097/00000658-197711000-00014.
2
[Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].[非乳腺恶性肿瘤转移至乳腺:28例临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2014 Apr;43(4):231-5.
3
Pancreatic involvement by metastasizing neoplasms as determined by endoscopic ultrasound-guided fine needle aspiration: A clinicopathologic characterization.经内镜超声引导下细针穿刺确定的转移性肿瘤累及胰腺:临床病理特征
Diagn Cytopathol. 2017 May;45(5):418-425. doi: 10.1002/dc.23688. Epub 2017 Feb 16.
4
Determination of primary site by examination of cancer cells in body fluids.通过检测体液中的癌细胞来确定原发部位。
Am J Clin Pathol. 1972 Nov;58(5):479-88. doi: 10.1093/ajcp/58.5.479.
5
Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.通过检查浆液性液体中的脱落肿瘤细胞来鉴定恶性肿瘤的类型和原发部位。与小组织活检的诊断准确性进行比较。
Acta Cytol. 1985 Sep-Oct;29(5):753-67.
6
The utility of fine-needle aspiration in the diagnosis of primary and metastatic tumors to the lung: a retrospective examination of 1,032 cases.细针穿刺抽吸术在诊断原发性及转移性肺肿瘤中的应用:1032例回顾性研究。
Acta Cytol. 2012;56(6):590-5. doi: 10.1159/000342935. Epub 2012 Nov 24.
7
Exfoliative cytology of metastatic cancer in lung.肺部转移性癌的脱落细胞学检查
Acta Cytol. 1968 Jan-Feb;12(1):61-74.
8
Visceral neoplasia presenting at the umbilicus.发生于脐部的内脏肿瘤。
J Surg Oncol. 1979;11(4):351-9. doi: 10.1002/jso.2930110410.
9
[Diagnosis and surgical treatment of metastatic lung tumors].[转移性肺肿瘤的诊断与外科治疗]
Gan To Kagaku Ryoho. 1996 Sep;23(10):1248-54.
10
Secondary tumors of the pancreas: clinicopathological study of 103 autopsy cases of Japanese patients.胰腺继发性肿瘤:103例日本患者尸检病例的临床病理研究
Pathol Int. 2001 Sep;51(9):686-90. doi: 10.1046/j.1440-1827.2001.01258.x.

引用本文的文献

1
Metachronous Mediastinal Cancers of Unknown Primary: A Case of Sequential Squamous Cell Carcinoma and Adenocarcinoma in Thoracic Lymph Nodes.原发灶不明的异时性纵隔癌:1例胸内淋巴结先后出现鳞状细胞癌和腺癌的病例
Cureus. 2025 Jun 22;17(6):e86526. doi: 10.7759/cureus.86526. eCollection 2025 Jun.
2
Diagnostic Challenges and Multidisciplinary Management of Invasive Mediastinal Adenocarcinoma: A Case Report.侵袭性纵隔腺癌的诊断挑战与多学科管理:一例报告
Cureus. 2025 May 28;17(5):e84995. doi: 10.7759/cureus.84995. eCollection 2025 May.
3
Long-Term Survival after Treatment with Induction Therapy and Surgery for Mediastinal Carcinoma of Unknown Primary.诱导治疗联合手术治疗原发性不明纵隔癌后的长期生存情况
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.24-0011. Epub 2025 Feb 22.
4
An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy.CK5/6、CK7和CK20在转移性宫颈淋巴结病细胞块中的免疫组化表达
Int J Appl Basic Med Res. 2022 Jul-Sep;12(3):171-176. doi: 10.4103/ijabmr.ijabmr_813_21. Epub 2022 Jul 26.
5
Microsatellite Instability-high-positive Cancer of Unknown Primary Origin with a Long-term Survival after Surgery Alone.原发灶不明的高度微卫星不稳定型肿瘤,单纯手术后长期生存
Intern Med. 2022 Nov 1;61(21):3301-3308. doi: 10.2169/internalmedicine.9218-21. Epub 2022 May 31.
6
Cancer of Unknown Primary: Challenges and Progress in Clinical Management.原发灶不明癌:临床管理中的挑战与进展
Cancers (Basel). 2021 Jan 25;13(3):451. doi: 10.3390/cancers13030451.
7
Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.初诊时原发灶不明的骨转移:286例回顾性分析
PLoS One. 2015 Jun 26;10(6):e0129428. doi: 10.1371/journal.pone.0129428. eCollection 2015.
8
Relapsed cervicomediastinal lymph node carcinoma with an unknown primary site treated with TS-1 alone: a case report.单独使用替吉奥治疗原发灶不明的复发性颈纵隔淋巴结癌:一例报告
BMC Res Notes. 2013 Dec 27;6:558. doi: 10.1186/1756-0500-6-558.
9
Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.类癌肿瘤:根据转移部位预测原发肿瘤的位置。
Eur Radiol. 2013 Feb;23(2):400-7. doi: 10.1007/s00330-012-2615-y. Epub 2012 Aug 30.
10
Carcinomas of an unknown primary origin--diagnosis and treatment.不明原发灶癌——诊断与治疗。
Nat Rev Clin Oncol. 2011 Nov 1;8(12):701-10. doi: 10.1038/nrclinonc.2011.158.

本文引用的文献

1
RESPONSE OF PRIMARY UNKNOWN CANCERS TO TREATMENT WITH 5-FLUOROURACIL (NSC-19893).原发性不明癌症对5-氟尿嘧啶(NSC-19893)治疗的反应
Cancer Chemother Rep. 1964 May;38:63-4.
2
CARCINOMA OF THE NECK.颈部癌
Am J Surg. 1963 Dec;106:974-9. doi: 10.1016/0002-9610(63)90166-1.
3
Metastatic cancer without a detectable primary site.无法检测到原发部位的转移性癌症。
Am J Surg. 1967 May;113(5):633-7. doi: 10.1016/0002-9610(67)90309-1.
4
Metastatic cancer of unknown primary site.原发部位不明的转移性癌
Cancer. 1970 Oct;26(4):816-20. doi: 10.1002/1097-0142(197010)26:4<816::aid-cncr2820260413>3.0.co;2-r.
5
Chemotherapy in the management of metastatic cancer of unknown primary site.不明原发部位转移性癌治疗中的化疗
Oncology. 1972;26(2):265-70. doi: 10.1159/000224675.
6
Metastatic neoplasms to the head and neck.头颈部转移性肿瘤。
Surg Gynecol Obstet. 1971 Oct;133(4):673-7.
7
Tumours of unknown origin.原发灶不明的肿瘤。
Recent Results Cancer Res. 1973;41:302-5. doi: 10.1007/978-3-642-80725-1_18.
8
Cervical lymph node metastasis: unknown primary cancer.颈部淋巴结转移:原发癌不明。
Cancer. 1973 Apr;31(4):854-9. doi: 10.1002/1097-0142(197304)31:4<854::aid-cncr2820310414>3.0.co;2-d.
9
Treatment of the patient with adenocarcinoma of unknown origin.对原发灶不明的腺癌患者的治疗。
Cancer. 1972 Dec;30(6):1469-72. doi: 10.1002/1097-0142(197212)30:6<1469::aid-cncr2820300609>3.0.co;2-t.
10
Metastatic potential of metastases.转移灶的转移潜能
Surgery. 1976 Jun;79(6):669-73.